GLOBAL RESEARCH ARCHIVE
Temenos AG: additiv acquisition: strengthening the wealth expansion
Research evidence excerpt
Temenos AG: additiv acquisition: strengthening the wealth expansion
Accessible version
Temenos AG
additiv acquisition: strengthening the
wealth expansion
Reiterate Rating: BUY | PO: 98.40 CHF | Price: 70.00 CHF
Breaking News 08 June 2026
Equity• Temenos acquires additiv. a mass affluent wealth management platform, to support
ambitions in Wealth. Reit Buy. Frederic Boulan, CFA >>
Research Analyst
• 50/50% cash/equity structure despite limited size (est $10-15mln revenue, c$0.2bn MLI (UK)
EV), but buy backs remain on the table +44 20 7995 7101
frederic.boulan@bofa.com
• Small but fast growth asset with 138% NRR, double digit growth. Ebner/ Patinex Victor Cheng, CFA >>
ownership (25% TEMN, 28% additiv) well flagged Research Analyst
MLI (UK)
+44 20 7996 0272
victor.cheng@bofa.com
Additiv acquisition to strengthen Wealth offering Carla Courthial >>
This morning Temenos announced the acquisition for mass affluent wealth management Research Analyst
platform additiv. The acquisition should help Temenos leverage the underlying trend of 44 77 6120 0059
generational wealth transfer, with a switch in demand towards digital solutions, with EM carla.courthial@bofa.com
in particular being a large and fast growing opportunity. Private banks, a core segment Aditya Buddhavarapu, CFA >>
of Temenos, are also increasingly developing that segment. No terms were disclosed MLI (UK)
beyond marginally accretive to ARR and subscription and SaaS. We view this acquisition +44aditya.buddhavarapu@bofa.com20 7995 7318
as strengthening Temenos Wealth business (c10% of total revenue) with a product able
to unlock faster time to market with 3-6m implementations with industry standards
>12months. Reiterate Buy on: 1/ continued improving execution in 2026/2027 supported
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer